Biotec Services International

Business profile

Location: Bridgend

Sector: Pharmaceuticals

Web site: www.biotec-uk.com

Investment

Total: £750,000

Type: Debt

Rounds: 2

Completed by: Dave Perez and Nick Larcombe

Why we invested

Biotec is a leading UK clinical trials supply company. It specialises in importing, labelling, storing and distributing supplies for pharmaceuticals companies around the world. It operates in the niche cold chain market, storing clinical supplies at temperatures as low as -196 degrees.

Biotec has grown steadily since Finance Wales' first investment. In 2010 the company required a £250,000 loan to help facilitate its MBO.

Outcome

Under new management, Biotec exceeded its sales projections in 2011 and required a second investment round. This enabled it to grow the business by expanding its purpose-built facilities. By achieving its growth plans, the company was able to expand in Asian, Israeli and US markets.

2011 was a landmark year for Biotec and its consistent, sustainable and profitable growth was recognised by a raft of industry awards. The company won the Outstanding Growth Award at the prestigious MediWales Awards and the Fast Growth 50 Sustainable Growth Award and was named Company of the Year at the 2011 IWA Western Mail Business Awards.

Testimonials

"Biotec is a strong company, performing well and we're delighted its sustainable growth strategy is earning the company the recognition it deserves." Dave Perez, Senior Portfolio Executive, Finance Wales.

"Biotec is proud of its long-term relationship with Finance Wales. We're planning further growth in key strategic markets in 2012, which Finance Wales' investments and expertise will underpin." Keren Winmill, CEO, Biotec Services International.